These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9587077)

  • 21. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head and neck cancer: altered fractionation schedules.
    Saunders MI
    Oncologist; 1999; 4(1):11-6. PubMed ID: 10337367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
    Poddar J; Sharma AD; Kunikullaya SU; Neema JP
    Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
    Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH
    Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered fractionation in the treatment of head and neck cancer.
    Hu KS; Harrison LB
    Curr Oncol Rep; 1999; 1(2):110-23. PubMed ID: 11122807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity.
    Skladowski K; Maciejewski B; Golen M; Pilecki B; Przeorek W; Tarnawski R
    Radiother Oncol; 2000 May; 55(2):101-10. PubMed ID: 10799721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.
    Mohan R; Wu Q; Manning M; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):619-30. PubMed ID: 10701741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.
    Shuryak I; Hall EJ; Brenner DJ
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):272-278. PubMed ID: 30776451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer.
    Mortensen HR; Overgaard J; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen LJ; Andersen E; Grau C
    Radiother Oncol; 2012 Apr; 103(1):69-75. PubMed ID: 22398313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.
    Fowler JF
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):8-22. PubMed ID: 17305251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
    Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
    Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective randomized trial to compare accelerated (six fractions a week) radiotherapy against concurrent chemoradiotherapy (using conventional fractionation) in locally advanced head and neck cancers.
    Gupta M; Mahajan R; Kaushal V; Seem RK; Gupta M; Bhattacharyya T
    J Cancer Res Ther; 2015; 11(4):723-9. PubMed ID: 26881508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
    Ho KF; Fowler JF; Sykes AJ; Yap BK; Lee LW; Slevin NJ
    Acta Oncol; 2009; 48(3):431-9. PubMed ID: 18781445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
    Terhaard CH; Kal HB; Hordijk GJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.